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SOS study design
After recruitment campaigns in the mass media and at 480 primary health-care centers, a matching examination was completed by 6905 patients, 5335 of which were eligible. Among them, 2010 individuals electing surgery formed the surgery group, and a matched control group of 2037 individuals was contemporaneously created using 18 matching variables. The matching variables were sex, age, weight, height, waist and hip circumferences, systolic blood pressure, serum cholesterol and triglyceride levels, smoking status, diabetes, menopausal status, four psychosocial variables with documented associations with the risk of death, and two personality traits related to treatment preferences. A matching algorithm selected controls so that the current mean values of the matching variables in the control group became as similar as possible to the current mean values in the surgery group according to the method of sequential treatment assignment. 1 The inclusion and exclusion criteria were identical for the two study groups, and all participants were eligible for surgery. The inclusion criteria were aged 37 to 60 years and BMI of 34 kg/m 2 or more for men and 38 kg/m 2 or more for women before or at the matching examination. The BMI cutoffs corresponded to an approximate doubling in the rate of death in men and women. 2 The exclusion criteria were earlier surgery for gastric or duodenal ulcer, earlier bariatric surgery, gastric ulcer during the past 6 months, ongoing malignancy, active malignancy during the past 5 years, myocardial infarction during the past 6 months, 1.12). The SOS study was started before repeated measurements were routinely used for the diagnosis of type 2 diabetes and single fasting glucose determinations were therefore used. Self-reported medication was obtained from SOS questionnaires. 1 : Adjusted for preselected risk factors age, sex, BMI, blood pressure, urinary albumin excretion, and smoking at baseline. 2 : Propensity score weighting: based on the baseline levels of the 18 matching variables (sex, age, weight, height, waist and hip circumferences, systolic blood pressure, serum cholesterol and triglyceride levels, smoking status, diabetes, menopausal status, four psychosocial variables with documented associations with the risk of death, and two personality traits related to treatment preferences) used in the recruitment to the SOS study, probability of receiving surgery was estimated with a probit model.
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This estimated probability (propensity score) was then used to weight the observations with weight of 1/(estimated probability) for the surgery patients, 1/(1-estimated probability) for the control patients to obtain inverse-probability-of-treatment-weighted estimator of treatment effect. All surgery and control patients were included in the analysis. 3 : Propensity score matching: The propensity score was used to match surgery patients to similar control patients using a caliber of 0.2 of standard deviation of the logit of the propensity score. A total of 1391 surgery patients (out of the total of 2001 patients, 70.0%) were matched to a control patient; thus 2782 surgery and control patients were included in the analysis. The dependence of the matched pairs were accounted for with a shared frailty in the Cox models. The following Anatomical Therapeutical Chemical (ATC) classification system codes were used: Antihypertensive drugs: B01A,C02,C03,C07,C08,C09 ARB and ACE-inhibitors: C02, C09A, C09B Lipid-lowering drugs: B04, C10 Diabetes drugs: oral medication or insulin, corresponding to ATC-class A1 Figure S1 . Body weight changes after bariatric surgery or usual care in subgroups of the Swedish Obese Subjects Study stratified by baseline glucose status.
Euglycemia, normal fasting glucose; Prediabetes, impaired fasting glucose; ST2D, screen-detected type 2 diabetes; T2D, type 2 diabetes. HR, hazard ratio; HRa, adjusted hazard ratio; T2D, type 2 diabetes, ST2D, screen detected type 2 diabetes.
